Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. \DE\LNDC · Entity 6447 | Director | October 20, 2016 | October 26, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LIFECORE BIOMEDICAL, INC. \DE\
Report date October 20, 2016 · Filed October 26, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectHeld in Trust | 52,914 |
Reported balance
After 2016-10-20 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2016-10-20 · Exercise / conversion · Acquired 2,201 · Balance 52,914 F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $13.80 · Expires 2016-10-20 | IndirectHeld in Trust | 0 |
Reported balance
After 2016-10-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2016-10-20 · Exercise / conversion · Disposed 2,201 · Balance 0 F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2: The restricted stock units were granted on May 25, 2016. F3: The restricted stock units vested on October 20, 2016. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.
F2: The restricted stock units were granted on May 25, 2016.
F3: The restricted stock units vested on October 20, 2016.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 20, 2016 Filed Oct 26, 2016 21:50 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Units · Derivative | 2,201 | $0.00 Strike: $13.80 | $0.00 |
DisclosureSEC source: 0001437749-16-040364 · rdgdoc.xml · derivative · entry 2 TOMPKINS NICHOLAS · CIK 0001145265 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 0 Underlying: Common Stock · 2,201 shares Expires 2016-10-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on May 25, 2016. F3 · derivative.exercise_date: The restricted stock units vested on October 20, 2016. F3 · derivative.expiration_date: The restricted stock units vested on October 20, 2016. Read SEC document |
| October 20, 2016 Filed Oct 26, 2016 21:50 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionCommon Stock | 2,201 | $13.80 | $30,373.80 |
DisclosureSEC source: 0001437749-16-040364 · rdgdoc.xml · nonDerivative · entry 1 TOMPKINS NICHOLAS · CIK 0001145265 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 52,914 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.